Joslin Diabetes Center
Boston, Massachusetts, 02215, United States
NCT Number: NCT03531021
This study is evaluating how to encourage teens to engage in heart healthy behaviors such as being more active or eating in a healthy way. Teens will be randomly assigned to either the usual care group or the group with education, goal-setting, and lifestyle challenges with teammates.
Looking for future studies?
Notify Me14 year–19 year
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02215, United States
Specific Aim: To develop and pilot test a modular intervention to improve heart healthy self-efficacy and behaviors in teens with type 1 diabetes at elevated cardiovascular disease risk.
Intervention Objective: To evaluate the feasibility and efficacy of a psychoeducational and behavioral intervention to improve heart healthy self-efficacy and behaviors in youth with type 1 diabetes (T1D) at elevated cardiovascular disease (CVD) CVD risk.
Secondary Objective: Assess participation in challenges involving healthy eating and physical activity.
Synopsis of Study Design
Study Design: Randomized, attention-matched trial with 1:1 randomization at a single center. Subjects will be randomized in two strata, by age (14-16 years and 17-19 years).
Study Population: Teens with type 1 diabetes.
Intervention: This pilot study involves a 6-month randomized controlled trial (RCT) comparing 2 study conditions, the behavioral intervention vs. an attention control. Youth will be randomized in 2 strata, by age (14-16 years and 17-19 years). Enrollment will end after 60 participants.
The intervention group will receive 2 modules (one in in person and one by video conference) and will receive follow-up phone calls/emails by study staff 3 weeks following each visit to review education and strategies for and barriers to reaching goals. Intervention sessions must include teen; parents may attend if they wish. Challenges will occur every 2 weeks. Participants will be on teams of about 3-5 teens and the teams may change over the course of the intervention due to staggered enrollment. As team members finish the study, newly randomized teammates will be assigned.
There will be a delayed intervention for the control group with study handouts after 3 months. The control group will meet with the research assistants (RAs) for demographic and survey completion and receive reminder phone calls/emails in order to match for attention.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intervention consists of educational modules, goal setting and brainstorming around strategies and barriers, and a series of heart healthy challenges such as walking a certain number of steps or eating healthy foods a certain number of times in a week.
Time frame: 3 months
healthy eating questionnaire, 23 question true/false survey, score range from 0-23, higher scores indicate healthier habits, no subscales.
Time frame: 3 months
changes in zbmi
Time frame: 3 months
Changes in blood pressure percentile
Time frame: 3 months
Changes in lipid levels from before study until study end
Time frame: 3 months
Documentation of how active participants were during study
Time frame: 3 months
evaluation of self-efficacy for exercise
Time frame: 3 months
healthy eating self-efficacy measure
Time frame: 3 months
evaluation of how confident participants are that they can eat in a healthy way
Time frame: 3 months
brief questions to evaluate willingness to take medication if prescribed
Time frame: 3 months
Proportion of intervention participants who completed challenges
Time frame: 3 months
change in weight in kg between enrollment and study completion
Joslin Diabetes Center
Other
Increasing Heart Healthy Behaviors in Youth With Type 1 Diabetes: A Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03761186
Autoimmune Diseases, Diabetes Mellitus
Stockholm, Sweden
View Trial DetailsNCT05662267
Autoimmune Diseases, Chronic Disease
Lille, France
View Trial DetailsNCT03396146
Autoimmune Diseases, Chronic Disease
Paris, France
View Trial DetailsNCT03973827
Autoimmune Diseases, Diabetes Mellitus
Huddinge, Sweden
View Trial Details